Management — NMD Pharma
Company Presentation
Annual Report 2019 by Lundbeckfonden - issuu
Redalyc.Endocrine disruptors: strategies for determination and occurrence in marine environments
Management — NMD Pharma
R3: Reviews, Responses & Reflections in Neuroscience by utneuro - issuu
Annual Report 2016 by Lundbeckfonden - issuu
65% 460 175+ 150+
Agenda - Neurotech Partnering
Rare Neuromuscular Disease Company NMD Pharma Raises USD 3 Million in Seed Financing Round - Lundbeckfonden
NMD Pharma | The Org
Thomas Holm Pedersen - Crunchbase Person Profile
Management — NMD Pharma
Company Presentation
Management — NMD Pharma
Management — NMD Pharma
PDF) CIC-1 chloride channels: State-of-the-art research and future challenges
Annual Report 2017 by Lundbeckfonden - issuu
Management — NMD Pharma
Company Presentation
Company Presentation
Denmark in New York on Twitter: "#DKBIO17 is "a great opportunity for us to broaden our scope and look for investors.” - Thomas H. Pedersen, CEO, NMD Pharma… https://t.co/AUeO5JqgX6"
Company Presentation
Company Presentation
Management — NMD Pharma
65% 460 175+ 150+
